| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ramsay B et al. | Blistering, erosions and scarring in a patient on etretinate. | 1989 | Br. J. Dermatol. | pmid:2529895 |
| Kellum RE | Papillon-Lefèvre syndrome in four siblings treated with etretinate. A nine-year evaluation. | 1989 | Int. J. Dermatol. | pmid:2531126 |
| Magyarlaki M et al. | [A case of erythrokeratodermia figurata variabilis successfully treated with tigason]. | 1989 | Z. Hautkr. | pmid:2531508 |
| David M et al. | Erythema multiforme-like eruptions associated with etretinate therapy. | 1989 | Clin. Exp. Dermatol. | pmid:2531640 |
| Casado M et al. | Keratoderma palmoplantaris striata. | 1989 | Clin. Exp. Dermatol. | pmid:2531641 |
| Larsen FG et al. | Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis. | 1989 | Pharmacol. Toxicol. | pmid:2533684 |
| Török L et al. | Bone-scintigraphic examinations in patients treated with retinoids: a prospective study. | 1989 | Br. J. Dermatol. | pmid:2534736 |
| Rollman O et al. | Etretinate and human adrenal function. | 1989 | J. Am. Acad. Dermatol. | pmid:2536409 |
| Euvrard S et al. | [Warts and epidermoid carcinoma after renal transplantation]. | 1989 | Ann Dermatol Venereol | pmid:2545155 |
| Lammer E | Etretinate and pregnancy. | 1989 | Lancet | pmid:2562875 |
| Rinck G et al. | Duration of contraception after etretinate. | 1989 | Lancet | pmid:2564929 |
| Raynaud F et al. | A cAMP binding abnormality in psoriasis. | 1989 | Lancet | pmid:2566733 |
| Vane FM et al. | Identification of etretinate metabolites in human bile. | 1989 May-Jun | Drug Metab. Dispos. | pmid:2568908 |
| Vane FM et al. | Identification of etretinate metabolites in human blood. | 1989 May-Jun | Drug Metab. Dispos. | pmid:2568909 |
| Tfelt-Hansen P et al. | Spinal cord compression after long-term etretinate. | 1989 | Lancet | pmid:2569118 |
| Dwyer JM et al. | Vasculitis and retinoids. | 1989 | Lancet | pmid:2570197 |
| Harrison PV | Vasculitis and retinoids. | 1989 | Lancet | pmid:2571001 |
| Niinimäki A et al. | Etretinate reduces connective tissue degeneration in lichen sclerosus et atrophicus. | 1989 | Acta Derm. Venereol. | pmid:2572115 |
| Thongnopnua P et al. | The pharmacokinetics of etretinate and its metabolites in the dog. | 1989 Sep-Oct | Drug Metab. Dispos. | pmid:2573489 |
| Keukens F et al. | Xeroderma pigmentosum: squamous cell carcinoma of the tongue. | 1989 | Acta Derm. Venereol. | pmid:2575331 |
| Kochhar DM et al. | Biotransformation of etretinate and developmental toxicity of etretin and other aromatic retinoids in teratogenesis bioassays. | 1989 Nov-Dec | Drug Metab. Dispos. | pmid:2575497 |
| Brouwer KR and McNamara PJ | Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. I. Intravenous studies. | 1989 Nov-Dec | Drug Metab. Dispos. | pmid:2575501 |
| Brouwer KR and McNamara PJ | Influence of pregnancy on the pharmacokinetic disposition of two aromatic retinoids (etretinate and acitretin) in the rat. II. Single and multiple oral dosing studies. | 1989 Nov-Dec | Drug Metab. Dispos. | pmid:2575502 |
| Traupe H and Happle R | Etretinate therapy in children with severe keratinization defects. | 1985 | Eur. J. Pediatr. | pmid:2580708 |
| Gimenez Garcia R et al. | Impetigo herpetiformis: response to steroids and etretinate. | 1989 | Int. J. Dermatol. | pmid:2583898 |
| Seishima M et al. | [A case of psoriasis vulgaris whose lipoprotein lipase activity decreased during treatment with etretinate]. | 1989 | Nihon Hifuka Gakkai Zasshi | pmid:2585775 |
| Garioch J and Simpson NB | Etretinate and severe nail plate dystrophies. | 1989 | Clin. Exp. Dermatol. | pmid:2591087 |
| Archer CB et al. | Extensive spinal hyperostosis in a patient receiving isotretinoin--progression after 4 years of etretinate therapy. | 1989 | Clin. Exp. Dermatol. | pmid:2591100 |
| Murphy GM and Griffiths WA | Aphthous ulcers responding to etretinate--a case report. | 1989 | Clin. Exp. Dermatol. | pmid:2591103 |
| pmid:25919143 | ||||
| Toombs EL and Peck GL | Electrosurgical treatment of etretinate-resistant Darier's disease. | 1989 | J Dermatol Surg Oncol | pmid:2592667 |
| Desablens B et al. | [Manifestations of Hodgkin's disease caused by retinoids?]. | 1989 Jul-Aug | Therapie | pmid:2595650 |
| McDonagh AJ and Harrington CI | Pseudoporphyria complicating etretinate therapy. | 1989 | Clin. Exp. Dermatol. | pmid:2605807 |
| Heule F et al. | Three long-term regimens with cyclosporin for psoriasis vulgaris. | 1989 | Acta Derm Venereol Suppl (Stockh) | pmid:2609861 |
| Stosić-Grujicić S et al. | In vitro effects of Ro 10-9359 on lectin-induced activation and proliferation of T lymphocytes. | 1989 | Acta Derm Venereol Suppl (Stockh) | pmid:2609871 |
| Mozzato MG et al. | Red blood cell membrane cation transport in normotensive psoriatics. | 1989 | Acta Derm Venereol Suppl (Stockh) | pmid:2609881 |
| Trevisan G et al. | Psoriatic microangiopathy modifications induced by PUVA and etretinate therapy. A nail-fold capillary microscopic study. | 1989 | Acta Derm Venereol Suppl (Stockh) | pmid:2609884 |
| Fléchet ML et al. | [Subungual multiple keratoacanthoma]. | 1989 | Ann Dermatol Venereol | pmid:2619190 |
| Altomare G et al. | [Exfoliative cytology of psoriasis: effects of cyclosporin A]. | 1989 Jul-Aug | G Ital Dermatol Venereol | pmid:2628276 |
| pmid:26283448 | ||||
| Simonetti O and Messini L | [Effect of etretinate treatment on fluidity and lipid composition of the erythrocyte membrane in patients with psoriasis]. | 1989 Nov-Dec | G Ital Dermatol Venereol | pmid:2638642 |
| Ward PS and Jones RD | Successful treatment of a harlequin fetus. | 1989 | Arch. Dis. Child. | pmid:2640554 |
| Allen JG and Bloxham DP | The pharmacology and pharmacokinetics of the retinoids. | 1989 | Pharmacol. Ther. | pmid:2645583 |
| Ferguson J and Johnson BE | Retinoid associated phototoxicity and photosensitivity. | 1989 | Pharmacol. Ther. | pmid:2645585 |
| Matt L et al. | Newer retinoids for psoriasis--early clinical studies. | 1989 | Pharmacol. Ther. | pmid:2645588 |
| Marsden JR | Lipid metabolism and retinoid therapy. | 1989 | Pharmacol. Ther. | pmid:2645591 |
| Hönigsmann H and Wolff K | Results of therapy for psoriasis using retinoid and photochemotherapy (RePUVA). | 1989 | Pharmacol. Ther. | pmid:2645592 |
| McLelland J and Chu AC | Skin tumours in renal allograft recipient. | 1989 | J R Soc Med | pmid:2647986 |
| Boyd AS | An overview of the retinoids. | 1989 | Am. J. Med. | pmid:2653031 |
| Browman GP et al. | Etretinate blood levels in monitoring of compliance and contamination in a chemoprevention trial. | 1989 | J. Natl. Cancer Inst. | pmid:2654406 |
| Zabarino P et al. | [Ossification of the antibrachial interosseous membrane caused by etretinate]. | 1989 | Ann Dermatol Venereol | pmid:2660707 |
| Cuny JF et al. | [Rheumatologic effects of etretinate]. | 1989 | Ann Dermatol Venereol | pmid:2660711 |
| Yurdakök M et al. | Deleterious effect of etretinate in septicemia in mice. | 1989 | Dermatologica | pmid:2670622 |
| Martin A et al. | [A new case of hyperostosis induced by a retinoid]. | 1989 | Rev Rhum Mal Osteoartic | pmid:2688058 |
| Gligora M et al. | Psoriasis in the third age. | 1989 | Acta Derm Venereol Suppl (Stockh) | pmid:2692371 |
| Ruszczak Z et al. | [Laboratory and oligobiopsy studies of the liver in patients with psoriasis treated by the combination of Tigason-PUVA-cignoline (RePUVA+C)]. | 1989 Mar-Apr | Przegl Dermatol | pmid:2695977 |
| Takeichi T et al. | Darier's Disease Complicated by Schizophrenia Caused by a Novel ATP2A2 Mutation. | 2016 | Acta Derm. Venereol. | pmid:27025976 |
| Kuokkanen K | [Retinoid treatment of pediatric skin diseases]. | 1989 | Duodecim | pmid:2721405 |
| Hast R et al. | Absent clinical effects of retinoic acid and isoretinoin treatment in the myelodysplastic syndrome. | 1989 Jul-Aug | Hematol Oncol | pmid:2737610 |
| Sharpe RJ et al. | Complete resolution of Kaposi's sarcoma with systemic etretinate therapy in a patient with mycosis fungoides. | 1989 | J. Am. Acad. Dermatol. | pmid:2754062 |
| Sanchez-Conejo-Mir J and Camacho F | Nevoid basal cell carcinoma syndrome: combined etretinate and surgical treatment. | 1989 | J Dermatol Surg Oncol | pmid:2754091 |
| Collin S et al. | A harlequin baby survives. | 1989 Jul 12-18 | Nurs Times | pmid:2771694 |
| Klinkhoff AV et al. | Pilot study of etretinate in psoriatic arthritis. | 1989 | J. Rheumatol. | pmid:2778761 |
| Kelly GE et al. | Effects of oral retinoid (vitamin A and etretinate) therapy on photocarcinogenesis in hairless mice. | 1989 | Photochem. Photobiol. | pmid:2780816 |
| Belz J et al. | Successful treatment of a patient with Reiter's syndrome and acquired immunodeficiency syndrome using etretinate. | 1989 | J. Am. Acad. Dermatol. | pmid:2785542 |
| Rogers M and Scraf C | Harlequin baby treated with etretinate. | 1989 | Pediatr Dermatol | pmid:2798260 |
| Waisman Y et al. | Failure of etretinate therapy in twins with severe congenital lamellar ichthyosis. | 1989 | Pediatr Dermatol | pmid:2798261 |
| Simoni S et al. | [Bullous congenital ichthyosiform erythroderma in a mother and son]. | 1989 | G Ital Dermatol Venereol | pmid:2807392 |
| Fanti PA et al. | Multiple keratoacanthoma in discoid lupus erythematosus. | 1989 | J. Am. Acad. Dermatol. | pmid:2808804 |
| David M et al. | Keratosis lichenoides chronica with prominent telangiectasia: response to etretinate. | 1989 | J. Am. Acad. Dermatol. | pmid:2808843 |
| Ludera-Zimoch G and Rubisz-Brzezińska J | [A case of superficial disseminated actinic porokeratosis treated with an aromatic retinoid]. | 1989 Jan-Mar | Przegl Dermatol | pmid:2813819 |
| Lammers AM and van de Kerkhof PC | Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes. | 1987 | Br. J. Dermatol. | pmid:2823858 |
| Guzman de Fleury M et al. | Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies. | 1986 | Histol. Histopathol. | pmid:2856536 |
| Grote W et al. | Malformation of fetus conceived 4 months after termination of maternal etretinate treatment. | 1985 | Lancet | pmid:2860474 |
| Burge S and Ryan T | Diffuse hyperostosis associated with etretinate. | 1985 | Lancet | pmid:2862558 |
| Griffiths WA | Retinoids and dyskeratinising disorder. | 1985 | Lancet | pmid:2864568 |
| Archer CB et al. | Spinal hyperostosis and etretinate. | 1987 | Lancet | pmid:2882147 |
| Harrison PV et al. | Methotrexate and retinoids in combination for psoriasis. | 1987 | Lancet | pmid:2887804 |
| Woll PJ et al. | Lymphoma in patients taking etretinate. | 1987 | Lancet | pmid:2887849 |
| Halkier-Sørensen L | Menstrual changes in a patient treated with etretinate. | 1987 | Lancet | pmid:2887930 |
| Harrison PV | Retinoids and malignancy. | 1987 | Lancet | pmid:2889017 |
| Ruzicka T et al. | Treatment of HIV-induced retinoid-resistant psoriasis with zidovudine. | 1987 | Lancet | pmid:2892034 |
| Retinoids and malignancy. | 1987 | Lancet | pmid:2892082 | |
| Weber U et al. | Abnormal retinal function associated with long-term etretinate? | 1988 | Lancet | pmid:2893053 |
| Zachariae H | Dangers of methotrexate/etretinate combination therapy. | 1988 | Lancet | pmid:2893228 |
| Brown RD and Grattan C | Etretinate and vision. | 1988 | Lancet | pmid:2894513 |
| Lammer EJ | Embryopathy in infant conceived one year after termination of maternal etretinate. | 1988 | Lancet | pmid:2903308 |
| Hopf G and Mathias B | Teratogenicity of isotretinoin and etretinate. | 1988 | Lancet | pmid:2903358 |
| Embryopathy in infant conceived one year after termination of maternal etretinate: a reappraisal. | 1988 | Lancet | pmid:2903985 | |
| Lee SC et al. | In vitro and in vivo regulation of transglutaminase activity of mouse epidermal cells by various vitamin A compounds. | 1988 | J. Dermatol. | pmid:2906073 |
| Halkier-Sørensen L and Andresen J | A retrospective study of bone changes in adults treated with etretinate. | 1989 | J. Am. Acad. Dermatol. | pmid:2913084 |
| DiGiovanna JJ et al. | Etretinate. Persistent serum levels after long-term therapy. | 1989 | Arch Dermatol | pmid:2913962 |
| Carmichael AJ and Paul CJ | Reversible gynaecomastia associated with etritinate. | 1989 | Br. J. Dermatol. | pmid:2923800 |
| Bollag W | [The future of the retinoids]. | 1985 | Fortschr. Med. | pmid:2931338 |
| Hoting E and Wassilew SW | [Systemic retinoid therapy with etretinate in pachyonychia congenita]. | 1985 | Hautarzt | pmid:2933371 |
| Sivayathorn A and Tongnak S | Mutilating keratoderma of Vohwinkel: successful treatment with etretinate. | 1985 | J Med Assoc Thai | pmid:2934494 |
| Collins MR et al. | Etretinate photosensitivity. | 1986 | J. Am. Acad. Dermatol. | pmid:2936777 |
| Nazzaro V and Blanchet-Bardon C | Progressive symmetric erythrokeratodermia. Histological and ultrastructural study of patient before and after treatment with etretinate. | 1986 | Arch Dermatol | pmid:2937369 |
| Verner E and Rosenman D | [Pustular psoriasis during maintenance treatment with etretinate]. | 1986 | Harefuah | pmid:2940160 |
| Rajka G and Thune PO | On erythema annulare centrifugum-type of psoriasis. | 1979 | Acta Derm Venereol Suppl (Stockh) | pmid:294089 |
Etretinate
Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.
Cross Reference
Introduction
To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Etretinate?
Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Etretinate
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Etretinate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Etretinate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Etretinate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Etretinate?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Etretinate?
There are no associated biomedical information in the current reference collection.